Auctor: Gregory Harris
Date Creaturae: 15 Aprilis 2021
Date Update: 1 July 2024
Anonim
Genetics (Chromosomal Mutations and Cancer)
Video: Genetics (Chromosomal Mutations and Cancer)

Contentus

Quid est BCR test-geneticae ABL?

A test geneticae BCR ABL, et vultus mutationem in geneticae (mutatio) in certis Homo.

Chromosomes sunt quae contineant partes cellam tuam genes. Transierunt autem assignat aliam rationem partium DNA ab patrem tuum et matrem. Unicum quod determinat speciem ferunt notitia qualis altitudinis oculorum colorem.

Northmanni populus XLVI chromosomatum habet, XXIII dividitur in duo et duo in cellula se. Una est ex se chromosomatum matris par est, et alteram par est ex patre.

BCR ABL est mutationem, quae fit ex mixtura duarum genes, quae BCR et ABL. Aliquando suus 'vocavit gradatim evolvebat, mixturam gene.

  • In gene est Northmanni BCR ex numero chromosomatum XXII.
  • In gene est Northmanni ABL ex numero chromosomatum IX.
  • Et mutationem fit ABL BCR-pieces of BCR et ABL genes abrumpere et switch locis.
  • XXII Quod Homo in mutationem ostendit, ubi est coniuncta IX pars chromosomatum ex se.
  • XXII Quod Homo dicitur mutari propter quod suus 'Homo est Philadelphiae, in qua urbs primum Inquisitores inventus est.
  • BCR ABL, in gene mutationem quae est per rationem hereditario a parentibus. Est autem genus of Vicia narbonensis mutationem, quae tu non modo natus est ex eo. Vos adepto postea in vita.

BCR in gene-ostendit in ABL cum aegris quaedam genera leukemia et cancer cellulis in os medulla et album sanguinem. BCR ABL, in hoc paene omnibus aegris cum leukemia vocantur morbi genus myeloid leukemia (CML). Hoc etiam alio nomine CML inveteratus myelogenous leukemia. Ambo nomina idem referuntur ad morbo.


Gene-is quoque ABL est BCR in aliqua patientibus leukemia acutique Lymphoblastic (ALL) ac raro in patientibus acuti myelogenous leukemia (AML).

Tum medicamentis maxime efficax in ageretur quidam cancer aegris cum leukemia, BCR ABL gene mutationem. Has medicinas et in paucioribus latus effectus quam aliis cancer treatments. De eadem re medica, non effective agendo diversa causarum natura vel leukemia carcinomata sua.

Alia nomina: BCR, ABL1, BCR ABL1, fusionem, Philadelphiae Homo

Quid est illud ad usus?

A test BCR, ABL est plerumque solebat egritudo an imperare longos myeloid de leukemia (CML) aut acuti forma specifica Lymphoblastic leukemia (ALL) Omnes positivum, qui dicitur Philipp. PH-positivum modo sit Homo Philadelphiae inventa. A test, non est ad egritudo multimodas aliis leukemia.

In test etiam potest ad utendum;

  • Vide si cancer curatio est effective.
  • Vide si patientes estote ad certum processit ad resistendum curatio. Hoc enim modo usi quia curatio est non opus ut effective.

Quare id faciam ABL-geneticae opus est BCR test?

Vos may postulo a BCR ABL test, si salubria de longos myeloid leukemia (CML) PH-positivae sive Acute Lymphoblastic Leukemia (ALL). Haec includit:


  • lassitudine
  • Febris
  • Pondus damnum
  • Nocte sudores (nimia sudor, eumque cum dormienti)
  • Os et iuncturam dolor

PH-positivae sive apud populum CML Quidam habent omnes notae, vel mitis symptoms multum, maxime in mane gradus morbo. Sic ut vestri valetudinis curas provisor ut test is est, si vel integram comitem sanguis sanguinem test eventus ostendit quod non normalis. Vos should quoque tua provisor quisquam teneo si vos have symptoms qui de vobis. Et certa sunt, Philipp CML inventum primo facilius curatur.

Hic quoque opus est tibi ut si test esse tractata sunt currently in PH-positivae sive CML SERMON. In test potest auxilium vestris provisor si tibi videatur esse opus curatio.

Quod fit per BCR test-geneticae ABL?

A-abl BCR test test aut ratio dici solet sanguine et medulla biopsy cupiditas.

Si vos es questus in sanguinem test, valetudinis curas professionalem et accipies sanguinem vein a sample tui brachium, per parvum foramen acus transire. Acus post infertur sanguis parum aut collecta in phiala uitreo. Ut vos sentio parum cum aculeo acus transire vadit, vel egredi. Plerumque minus id elit.


Si vos es questus enim cupiditas et medullis ossa biopsy, te potest procedure includit sequenti gradus:

  • Latus aut ventrem tuum, youll 'tu dormies super latus tuum: os autem quod fretus esse iudicetur. Maxime probat os medulla, ex in os coxae sunt.
  • Purpura cooperiri corpus ut testis tantum circa situm ostendere.
  • Situs cum ANTISEPTICA REMEDIA et potest purgari debet.
  • Vos mos adepto an iniectio solution corpus rigens remittet. Sic ut dolorem.
  • Cum aream sed torpet, salutem cura provisor tollet gustatum. Vos mos postulo ut mentiri etiam in ipso probat.
    • Aspiratio ad os medulla, quae primum exercentur plerumque et salutem cura provisor et inserere per foramen acus transire ad trahendum manum, et os medulla mutuò æqualiter prement et cellulis. Te sentiunt, ut ex utraque parte acutus dolor sed brevis, ubi acus wdnexa est insertos surculos.
    • Nam et medullis ossa biopsy, in salutem cura provisor et uti a tool ut torquet specialis os in medullae ossium TEXTUS Domini ad manum exemplum. Ut quidam sentiunt pressura in in sample cum situm est sublatus.
  • It takes circiter X minuta in utraque praestare probat.
  • Post test, in salutem cura provisor obtegam, aspersione pulveris os site.
  • Consilium habere aliquem coegi vos domum suam: quoniam data est a leniendo potest coram probat, quam ut te faciente sponso dormitaverunt.

Et opus est facere quicquam praeparet pro test?

Et plerumque non indigent aliqua speciali apparatu in sanguine et medullis ossa test.

An ulla metus tentatis?

Parum autem sanguis periculo experiri. Levi dolor habeatis in livorem acu ad locum, sed abire propere salubria.

Medullae ossium post test, ut sentio valde rigida vel per iniectio site. Paucis plerumque abit. Et sanitas tua cura provisor ut suadeo ut dolorem reliever alicui auxilio.

Quid eventus medium?

Si vos have praecessi ostendam BCR ad gene-ABL, tum quod alius tantum album sanguinem cellulis, vos mos probabiliter potest praecogniti cum leukemia cum inveterata myeloid (CML) PH-positive vel acutis Lymphoblastic Leukemia (ALL).

Si vos es currently esse tractata, vel ad CML PH-positivum omnia tuus ut eventus ostendere:

  • Moles BCR ABL, in sanguine et medullis ossa crescit. Hoc curatio est non opus ut sit tibi et / vel tu facti quadam reluctans curatio.
  • Moles BCR ABL, in sanguine et medullis ossa descendit. Hoc curatio est opus, ut sit tibi.
  • Moles BCR ABL, in sanguine et medullis ossa non augeri potest vel minui. Et hoc ut firmum sit tibi morbus est.

Si habetis quaestiones circa vestri praecessi, loqui ad tuum valetudinis curas provisor.

Learn more about laboratorium expertus, referat extra septa templi, et intellectus results.

Aliud est non opus scire de BCR test-geneticae ABL?

Myeloid treatments vetustati leukemia (CML) et Ph-positivum, acutae Lymphoblastic leukemia (ALL) felix esse in patientibus leukemia sunt formae. Est momenti ad salutem cura provisor tuus semper fac opus tuum treatments permanere. Si resistat facti treatment, vestra provisor ut suadeo Lorem alia genera cancer.

Greek New

  1. American Cancer Congregatio [Internet]. Atlanta: American Cancer Congregatio Inc .; c2018. Quid CAUSARUM Longos Myeloid Leukemia [XIX Iun MMXVIII updated: Aug citatis MMXVIII I]; [Screens circa IV]. Available from: https://www.cancer.org/cancer/chronic-myeloid-leukemia/causes-risks-prevention/what-causes.html
  2. Cancer.net [Internet]. Alexandria (VA) de National American Societas Oncology; c2005-2018. Leukemia: chronicus Myeloid: CML Praefationes; Mar MMXVIII [citatis MMXVIII Aug I]; [Screens circa III]. Available from: https://www.cancer.net/cancer-types/leukemia-chronic-myeloid-cml/introduction
  3. Cancer.net [Internet]. Alexandria (VA) de National American Societas Oncology; c2005-2018. Leukemia: chronicus Myeloid: CML: Treatment Options: Mar MMXVIII [citatis MMXVIII Aug I]; [Screens circa IV]. Available from: https://www.cancer.net/cancer-types/leukemia-chronic-myeloid-cml/treatment-options
  4. Lab Online probat [Internet]. Washington D.C: Acta Historiae American Association for: c2001-2018. BCR, ABL1 [IV Dec MMXVII updated: Aug citatis MMXVIII I]; [Screens circa II]. Available from: https://labtestsonline.org/tests/bcr-abl1
  5. Lab Online probat [Internet]. Washington D.C: Acta Historiae American Association for: c2001-2018. Leukemia [XVIII Ian MMXVIII updated: Aug citatis MMXVIII I]; [Screens circa II]. Available from: https://labtestsonline.org/conditions/leukemia
  6. Leukemia et lymphoma Societas [Internet]. Torrens siliginis (NY): Society Leukemia et lymphoma, c2015. Longos Myeloid Leukemia [citatis MMXVIII Aug I]; [Screens circa III]. Available from: http://www.lls.org/leukemia/chronic-myeloid-leukemia
  7. Mayo Clinic [Internet]. Medical et Research Foundation Institutio et fungebatur; c1998-2018. Medullae ossium biopsy neque postulare, Overview; Ian MMXVIII XII [citatis MMXVIII Aug I]; [Screens circa IV]. Available from: https://www.mayoclinic.org/tests-procedures/bone-marrow-biopsy/about/pac-20393117
  8. Mayo Clinic [Internet]. Medical et Research Foundation Institutio et fungebatur; c1998-2018. Longos myelogenous leukemia: Overview; XXVI MMXVI Maii [citatis MMXVIII Aug I]; [Screens circa IV]. Available from: https://www.mayoclinic.org/diseases-conditions/chronic-myelogenous-leukemia/symptoms-causes/syc-20352417
  9. Mayo Clinic, Mayoensi Medical Laboratories [Internet]. Medical et Research Foundation Institutio et fungebatur; c1995-2018. Test ID: BADX: BCR / ABL1, Qualitative, Herpesvirus hominis feodis praedictis, Volume et Interpretive [citatis MMXVIII Aug I]; [Screens circa IV]. Available from: https://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/89006
  10. Consumer Merck Manual Version [Internet]. Kenell '(Linnaeus) Merck Belize & Co., Inc .; c2018. Et exploratum os medulla [citatis MMXVIII Aug I]; [Screens circa II]. Available from: http://www.merckmanuals.com/home/blood-disorders/symptoms-and-diagnosis-of-blood-disorders/bone-marrow-examination
  11. Consumer Merck Manual Version [Internet]. Kenell '(Linnaeus) Merck Belize & Co., Inc .; c2018. Longos Myelogenous Leukemia [citatis MMXVIII Aug I]; [Screens circa II]. Available from: https://www.merckmanuals.com/home/blood-disorders/leukemias/chronic-myelogenous-leukemia
  12. National Cancri Instituti [Internet]. Bethsatham (MD): US Department of Sanitas et Humanum Services; Longos Myelogenous Leukemia Sanatio (PDQ®) -Patient Version [citatis MMXVIII Aug I]; [Screens circa IV]. Available from: https://www.cancer.gov/types/leukemia/patient/cml-treatment-pdq
  13. National Cancri Instituti [Internet]. Bethsatham (MD): US Department of Sanitas et Humanum Services; Nulla a nisl Cancri targeted [citatis MMXVIII Aug I]; [Screens circa IV]. Available from: https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies/targeted-therapies-fact-sheet
  14. National Cancri Instituti [Internet]. Bethsatham (MD): US Department of Sanitas et Humanum Services; NCI dictionary Termini tropicum Cancri: BCR fusionem-ABL gene [citatis MMXVIII Aug I]; [Screens circa III]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bcr-abl-fusion-gene
  15. National Cancri Instituti [Internet]. Bethsatham (MD): US Department of Sanitas et Humanum Services; NCI dictionary Termini tropicum Cancri: BCR, ABL protein [citatis MMXVIII Aug I]; [Screens circa III]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/bcr-abl-fusion-protein
  16. National Cancri Instituti [Internet]. Bethsatham (MD): US Department of Sanitas et Humanum Services; NCI dictionary Termini tropicum Cancri: gene [citatis MMXVIII Aug I]; [Screens circa III]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/search?contains=false&q=gene
  17. National Cor Lung, sanguis Instituti [Internet]. Bethsatham (MD): US Department of Sanitas et Humanum Services; Sanguis probat [citatis MMXVIII Aug I]; [Screens circa III]. Available from: https://www.nhlbi.nih.gov/health-topics/blood-tests
  18. NIH Humanum Genome National Research Institute [Internet]. Bethsatham (MD): US Department of Sanitas et Humanum Services; Triticum abnormalities; Ian MMXVI VI [citatis MMXVIII Aug I]; [Screens circa III]. Available from: https://www.genome.gov/11508982
  19. NIH US National Library of Medicine: Reference Genetics Home [Internet]. Bethsatham (MD): US Department of Sanitas et Humanum Services; ABL1 gene; Iul XXXI MMXVIII [citatis MMXVIII Aug I]; [Screens circa II]. Available from: https://ghr.nlm.nih.gov/gene/ABL1#conditions
  20. Oncolink [Internet]. Philadelphiae: actoribus of the University of Pennsylvania; c2018. Omnia de Adult Lymphocytic Leukemia Acutis (ALL) [XXII Ian MMXVIII updated: Aug citatis MMXVIII I]; [Screens circa III]. Available from: https://www.oncolink.org/cancers/leukemia/leukemia-acute-lymphocytic-leukemia-all/all-about-adult-acute-lymphocytic-leukemia-all
  21. Oncolink [Internet]. Philadelphiae: actoribus of the University of Pennsylvania; c2018. Omnia de Longos Myeloid Leukemia (CML) [XI Oct MMXVII updated: Aug citatis MMXVIII I]; [Screens circa III]. Available from: https://www.oncolink.org/cancers/leukemia/chronic-myelogenous-leukemia-cml/all-about-chronic-myeloid-leukemia-cml

Et notitia in site si hoc non possunt, pro medicas curas professionalem seu consilium. Et contact salute vestra cura provisor si habetis quaestiones circa salutem.

Tibi

Quid scire de invasiones

Quid scire de invasiones

Quid inva ione ?Inva ione int mutatione in cerebrum criptor electrica operatio. Haec cau a mutatione pote t tragicu , noticeable ymptom , aut in alii ca ibu , non omnino indicia. igna autem capcio em...
Arthritis est scriptor syndrome et secundarium Sjogren

Arthritis est scriptor syndrome et secundarium Sjogren

Quid e t ecundarium jogren criptor yndrome? jogren criptor yndrome e t quod autoimmune inordinatio damna humorem-producen glanduli , facien illud difficile ad producere aliva, et lacrymarum. A morbo ...